Samyang Balance Sheet Health
Financial Health criteria checks 6/6
Samyang has a total shareholder equity of ₩1,841.9B and total debt of ₩911.6B, which brings its debt-to-equity ratio to 49.5%. Its total assets and total liabilities are ₩3,228.5B and ₩1,386.7B respectively. Samyang's EBIT is ₩141.3B making its interest coverage ratio -11.8. It has cash and short-term investments of ₩388.1B.
Key information
49.5%
Debt to equity ratio
₩911.62b
Debt
Interest coverage ratio | -11.8x |
Cash | ₩388.06b |
Equity | ₩1.84t |
Total liabilities | ₩1.39t |
Total assets | ₩3.23t |
Recent financial health updates
Is Samyang (KRX:145990) Using Too Much Debt?
Mar 22Samyang (KRX:145990) Has A Somewhat Strained Balance Sheet
Dec 22Recent updates
Key Things To Watch Out For If You Are After Samyang Corporation's (KRX:145990) 1.7% Dividend
Apr 14Is Samyang (KRX:145990) Using Too Much Debt?
Mar 22Samyang's (KRX:145990) Shareholders Are Down 45% On Their Shares
Mar 01Here's What Samyang Corporation's (KRX:145990) Shareholder Ownership Structure Looks Like
Feb 08Key Things To Consider Before Buying Samyang Corporation (KRX:145990) For Its Dividend
Jan 14Samyang Corporation (KRX:145990) Passed Our Checks, And It's About To Pay A ₩1,000 Dividend
Dec 23Samyang (KRX:145990) Has A Somewhat Strained Balance Sheet
Dec 22If You Had Bought Samyang's (KRX:145990) Shares Five Years Ago You Would Be Down 45%
Dec 01Financial Position Analysis
Short Term Liabilities: A145990's short term assets (₩1,143.0B) exceed its short term liabilities (₩821.4B).
Long Term Liabilities: A145990's short term assets (₩1,143.0B) exceed its long term liabilities (₩565.3B).
Debt to Equity History and Analysis
Debt Level: A145990's net debt to equity ratio (28.4%) is considered satisfactory.
Reducing Debt: A145990's debt to equity ratio has reduced from 62.2% to 49.5% over the past 5 years.
Debt Coverage: A145990's debt is well covered by operating cash flow (23.1%).
Interest Coverage: A145990 earns more interest than it pays, so coverage of interest payments is not a concern.